PIS
AZN icon

POM Investment Strategies’s AstraZeneca AZN Stock Holding History

POM Investment Strategies’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-14
Closed -$1.99K – 150
2025
Q1 		$1.99K Hold
14
– – ﹤0.01% 158
2024
Q4 		$1.77K Hold
14
– – ﹤0.01% 286
2024
Q3 		$2.1K Sell
14
-62
-82% -$10K ﹤0.01% 227
2024
Q2 		$11.8K Buy
76
+62
+443% +$9.33K 0.01% 171
2024
Q1 		$1.83K Hold
14
– – ﹤0.01% 202
2023
Q4 		$1.82K Buy
+14
New +$1.82K ﹤0.01% 188

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

POM Investment Strategies's AZN Position: Q2 2025 in Review

POM Investment Strategies sold out of AstraZeneca (AZN) in Q2 2025, closing a stake of 14 shares — an estimated $1.99K sold.

POM Investment Strategies first reported a position in AZN in Q4 2023 and held it in 6 quarters. The position peaked at $11.8K in Q2 2024. 1,223 funds tracked by Wall St. Rank hold AZN as of Q2 2025.

  • POM Investment Strategies reported no remaining AstraZeneca position as of Q2 2025 after selling out during the quarter.
  • POM Investment Strategies sold 14 AstraZeneca shares in Q2 2025, an estimated $1.99K.
  • POM Investment Strategies first reported a position in AstraZeneca in Q4 2023 and held it in 6 quarters.
  • POM Investment Strategies's AstraZeneca position peaked at $11.8K in Q2 2024.
  • 1,223 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2025.

Based on POM Investment Strategies's 13F filing for Q2 2025, filed 8 Aug 2025.